Published in
Elsevier, Kidney International, 1(97), p. 202-212, 2020
DOI: 10.1016/j.kint.2019.09.013
Links
Tools
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
Journal article published in 2020 by
Erik J. M. van Bommel 
,
Marcel H. A. Muskiet ,
Michaël J. B. van Baar,
Lennart Tonneijck,
Mark M. Smits,
Anna L. Emanuel,
Andrea Bozovic,
A. H. Jan Danser,
Frank Geurts,
Ewout J. Hoorn,
Daan J. Touw,
Emil L. Larsen,
Henrik E. Poulsen,
Mark H. H. Kramer,
Max Nieuwdorp
and other authors.
,
Marcel H. A. Muskiet ,
Michaël J. B. van Baar,
Lennart Tonneijck,
Mark M. Smits,
Anna L. Emanuel,
Andrea Bozovic,
A. H. Jan Danser,
Frank Geurts,
Ewout J. Hoorn,
Daan J. Touw,
Emil L. Larsen,
Henrik E. Poulsen,
Mark H. H. Kramer,
Max Nieuwdorp
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 